Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.53M | 31.80M | -108.02M | -107.68M | 162.24M |
| Total Depreciation and Amortization | 10.21M | 10.30M | 10.13M | 10.10M | 10.36M |
| Total Amortization of Deferred Charges | 922.80K | 930.80K | 876.60K | 873.90K | 387.30K |
| Total Other Non-Cash Items | 16.90M | 17.05M | 178.71M | 178.16M | -178.83M |
| Change in Net Operating Assets | -- | -- | -65.56M | -65.36M | -- |
| Cash from Operations | 59.56M | 60.08M | 16.14M | 16.09M | -5.85M |
| Capital Expenditure | -- | -- | -33.46M | -33.36M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 8.19M | 8.17M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 3.46M | 3.45M | 67.33M |
| Other Investing Activities | -27.75M | -27.99M | 3.50M | 3.49M | 29.15M |
| Cash from Investing | -27.75M | -27.99M | -18.30M | -18.25M | 96.48M |
| Total Debt Issued | 498.01M | 498.01M | 297.87M | 297.87M | 310.00M |
| Total Debt Repaid | -607.03M | -607.03M | -183.26M | -183.26M | -500.15M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -200.87M | -200.87M | -120.02M | -120.02M | -24.52M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -29.03M | -28.94M | -- |
| Other Financing Activities | 453.16M | 453.16M | 9.78M | 9.78M | -27.52M |
| Cash from Financing | 19.78M | 19.96M | -28.42M | -28.34M | -34.56M |
| Foreign Exchange rate Adjustments | 40.90K | 41.20K | 127.50K | 127.10K | 213.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.63M | 52.08M | -30.46M | -30.36M | 56.28M |